Neurodegenerative diseases affect millions of people worldwide, and cases are on the rise. Engineered antibodies detect and characterize markers of disease to aid our understanding of these conditions.
Specialists in antibody sequencing, engineering, and recombinant manufacturing.
Alzheimer’s disease (AD), Parkinson’s disease (PD), and other neurodegenerative diseases are complex and prescient subjects of research, characterized by the accumulation of misfolded proteins in the nervous system that exhibit pathogen behavior (Armstrong, 2020). With as many as 55 million people with AD or dementia and an estimated 8.5 million people with PD worldwide, and those numbers expected to rise, the need for comprehensive understanding of the pathways that contribute to neurodegenerative pathogenesis is only growing.
To aid in the specific, reliable detection and modulation of proteins like polysialic acid, amyloid beta, tau, and more, Absolute Antibody recombinantly engineers antibodies against relevant proteins implicated in neurodegenerative disease. Recent citations in the field of neurodegenerative disease research illustrate our antibodies in action.
The Absolute Antibody catalog offers recombinantly produced antibodies against relevant proteins in neurodegenerative disease research, like polysialic acid (Ab00240), amyloid beta (Ab00714 and Ab00239), and tau proteins (Ab00639) to ensure batch-to-batch reproducibility and enable antibody engineering. The antibodies are available off-the-shelf in different engineered formats, including mouse, rabbit and human species, as well as various isotypes and fragments. The antibodies can also be custom engineered into other formats upon request
Further, Absolute Antibody confirmed the specificity of the recombinantly produced clones. The figure below illustrates the purity (A), specificity (B, C), and activity (D, E) of our recombinant WO2 anti-Amyloid beta (Ab00239-2.0) antibody compared to a hybridoma-derived WO2 from Competitor M. More information can be found in our post about how recombinant amyloid beta antibodies support Alzheimer’s research.

If you can’t find what you need in our full catalog of neuroscience research antibodies, our antibody engineers can tailor any antibody or sequence to exactly what you need. Our custom services offerings include antibody engineering in every format, optimized antibody expression via our recombinant system, and antibody sequencing to protect your work. Please contact us for more information.
Absolute Antibody offers neurodegenerative disease research reagents from other brands within our parent company Absolute Biotech: goat polyclonal antibodies from Everest Biotech; antibodies and cell lines from Kerafast; and antibodies, proteins and ELISA kits from LSBio.
Specialists in antibody sequencing, engineering, and recombinant manufacturing.
We gladly support you by keeping you updated on our latest products and developments